Financials
Financial year 2024
JM Pharma Care from Andenne, company number BE0644685061, closed financial year 2024 with a result of € 26,696 after tax. For that financial year JM Pharma Care recorded a gross margin of € 148,025 and equity of € 177,363. Compared with financial year 2023, the result moved from € 27,166 to € 26,696. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 177,363
▲ 16% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 26,696
▼ 2% vs 2023
Profit after tax over the fiscal year.
€ 62,636
▲ € 57,939 vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 1,600 paid out
6 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
0.8
Average over the fiscal year, from the social balance sheet.
€ 33,604
▲ 1% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,367
▼ 40% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 433,161
▼ 14% vs 2023
€ 57,335 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 177,335
▼ 6% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 24,722
▲ 40% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 123,040 | € 170,268 | € 142,001 | € 148,025 | ▲ 4% |
| Profit after taxes | € 23,797 | € 31,396 | € 27,166 | € 26,696 | ▼ 2% |
| Equity | € 112,005 | € 112,901 | € 152,268 | € 177,363 | ▲ 16% |
| Total debts | € 867,738 | € 826,741 | € 749,078 | € 666,491 | ▼ 11% |
| Cash | € 59,469 | € 82,665 | € 4,697 | € 62,636 | ▲ € 57,939 |
| Land & buildings | € 547,732 | € 506,053 | € 458,150 | € 410,368 | ▼ 10% |
| Retained profit | € 105,805 | € 106,701 | € 132,268 | € 157,363 | ▲ 19% |
| Dividend | € 0 | € 30,500 | € 1,600 | € 1,600 | |
| Bank debt | € 669,249 | € 581,008 | € 502,368 | € 433,161 | ▼ 14% |
| Balance sheet total | € 979,743 | € 939,642 | € 901,345 | € 843,854 | ▼ 6% |
| Employees (FTE) | 0.8 | 0.8 | 0.8 | 0.8 |
Key figures of JM Pharma Care, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to JM Pharma Care?
What happened at JM Pharma Care in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 26,696 (▼ 2% vs 2023). filed late Source: NBB ↗
- New establishment in Andenne. KBO
- Julien WASCOTTE became a director. NBB
- Maud LINARD became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 23,797 profit in 2021 to € 26,696 profit in 2024.
Paid € 15,991 in corporate taxes since 2021.
Best year ever: 2022, with € 31,396 profit.
Paid out € 33,700 in dividends to the owners in total.
A new publication or filing at JM Pharma Care? We notify you, reason included.
Follow JM Pharma CareDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind JM Pharma Care are Julien WASCOTTE and Maud LINARD.
Directors
According to the 2024 annual accounts
Julien WASCOTTE
Director
since 2015
Maud LINARD
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Rue du Commerce 24
5300 Andenne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0644.685.061
- VAT number
- BE 0644.685.061
- Registered office
- Rue du Commerce 24, 5300 Andenne
- Names & denominations
- JM Pharma Care
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 December 2015
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Vervaardiging van geneesmiddelen
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Vervaardiging van farmaceutische grondstoffen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels